• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

采用液相色谱串联质谱法对人血浆和脑脊液中的奥雷巴替尼进行定量分析。

Quantification of orelabrutinib in human plasma and cerebrospinal fluid by liquid chromatography tandem mass spectrometry.

作者信息

Ji Shengnan, Liu Xiaomeng, Ha Jing, Ai Lianfeng, Li Zheng

机构信息

College of Chemical and Pharmaceutical Engineering, Hebei University of Science and Technology, 050018 Shijiazhuang, China.

Shijiazhuang Customs Technology Center, 050051 Shijiazhuang, China; College of Public Health, Hebei Medical University, 050017 Shijiazhuang, China.

出版信息

J Chromatogr B Analyt Technol Biomed Life Sci. 2023 Apr 15;1221:123680. doi: 10.1016/j.jchromb.2023.123680. Epub 2023 Mar 20.

DOI:10.1016/j.jchromb.2023.123680
PMID:36989941
Abstract

A sensitive and simple method was developed to determine orelabrutinib in human plasma and cerebrospinal fluid by liquid chromatography tandem mass spectrometry (LC-MS/MS). The samples were prepared by simple protein precipitation with by 0.1% formic acid acetonitrile solution and efficient separations were performed on the Thermo Hypersll GOLD C18 column (2.1 mm × 150 mm, 5 μm) under a gradient program in a total run time of 9 min. The orelabrutinib was detected by electrospray ionization in positive ion mode with selective reaction monitoring (SRM) and mass spectrometric conditions were optimized in order to increase selectivity and sensitivity. The developed method was validated in terms of its accuracy, precision, selectivity, linearity, recovery, matrix effect, stability, and limits of quantification (LOQ). The lower limit of quantification is 0.50 ng/mL, the intraday and interday precision RSD are both less than 15%, and the recovery rate is 85.7%-92.9%. Finally, the method was successfully applied for the quantitation of orelabrutinib in human plasma and cerebrospinal fluid of clinical patients treated with orelabrutinib.

摘要

建立了一种灵敏且简便的液相色谱串联质谱法(LC-MS/MS)测定人血浆和脑脊液中的奥雷巴替尼。样品采用0.1%甲酸乙腈溶液进行简单的蛋白沉淀法制备,并在Thermo Hypersll GOLD C18柱(2.1 mm×150 mm,5μm)上按照梯度程序进行高效分离,总运行时间为9分钟。奥雷巴替尼采用电喷雾电离正离子模式下的选择性反应监测(SRM)进行检测,并对质谱条件进行了优化以提高选择性和灵敏度。所建立的方法在准确性、精密度、选择性、线性、回收率、基质效应、稳定性和定量限(LOQ)方面进行了验证。定量下限为0.50 ng/mL,日内和日间精密度RSD均小于15%,回收率为85.7%-92.9%。最后,该方法成功应用于接受奥雷巴替尼治疗的临床患者人血浆和脑脊液中奥雷巴替尼的定量分析。

相似文献

1
Quantification of orelabrutinib in human plasma and cerebrospinal fluid by liquid chromatography tandem mass spectrometry.采用液相色谱串联质谱法对人血浆和脑脊液中的奥雷巴替尼进行定量分析。
J Chromatogr B Analyt Technol Biomed Life Sci. 2023 Apr 15;1221:123680. doi: 10.1016/j.jchromb.2023.123680. Epub 2023 Mar 20.
2
Simultaneous Determination of Orelabrutinib, Zanubrutinib, Ibrutinib and Its Active Metabolite in Human Plasma Using LC-MS/MS.采用 LC-MS/MS 法同时测定人血浆中的奥雷巴替尼、泽布替尼、伊布替尼及其活性代谢物。
Molecules. 2023 Jan 26;28(3):1205. doi: 10.3390/molecules28031205.
3
Quantification of cefaclor in human plasma using SIL-IS LC-ESI-MS/MS for pharmacokinetics study in healthy Chinese volunteers.采用 SIL-IS LC-ESI-MS/MS 定量检测健康中国志愿者人体血浆中的头孢克洛及其药代动力学研究。
Biomed Chromatogr. 2023 Aug;37(8):e5638. doi: 10.1002/bmc.5638. Epub 2023 May 16.
4
Determination of Orelabrutinib in Human Plasma Using LC-MS/MS.采用液相色谱-串联质谱法测定人血浆中的奥雷巴替尼
Ther Drug Monit. 2023 Oct 1;45(5):599-605. doi: 10.1097/FTD.0000000000001106. Epub 2023 May 5.
5
[Determination of quercetin in human serum by liquid chromatography-mass spectrometry].液相色谱-质谱法测定人血清中的槲皮素
Wei Sheng Yan Jiu. 2016 Jul;45(4):658-662.
6
Determination of geniposide in adjuvant arthritis rat plasma by ultra-high performance liquid chromatography tandem mass spectrometry method and its application to oral bioavailability and plasma protein binding ability studies.超高效液相色谱串联质谱法测定佐剂性关节炎大鼠血浆中栀子苷及其在口服生物利用度和血浆蛋白结合能力研究中的应用
J Pharm Biomed Anal. 2015 Apr 10;108:122-8. doi: 10.1016/j.jpba.2015.01.044. Epub 2015 Feb 7.
7
Determination of Pralsetinib in Human Plasma and Cerebrospinal Fluid for Therapeutic Drug Monitoring by Ultra-performance Liquid Chromatography-Tandem Mass Spectrometry (UPLC-MS/MS).采用超高效液相色谱-串联质谱法(UPLC-MS/MS)测定人血浆和脑脊液中普拉替尼的浓度用于治疗药物监测。
Anticancer Agents Med Chem. 2024;24(11):867-877. doi: 10.2174/0118715206290110240326071909.
8
A quantitative method for the simultaneous detection of SR9009 and SR9011 in equine plasma using liquid chromatography-electrospray ionization-tandem mass spectrometry.采用液相色谱-电喷雾串联质谱法检测马血浆中的 SR9009 和 SR9011 的定量方法。
Drug Test Anal. 2022 Aug;14(8):1532-1538. doi: 10.1002/dta.3271. Epub 2022 Apr 19.
9
Simultaneous determination of ten antiepileptic drugs in human plasma by liquid chromatography and tandem mass spectrometry with positive/negative ion-switching electrospray ionization and its application in therapeutic drug monitoring.采用正/负离子切换电喷雾电离的液相色谱-串联质谱法同时测定人血浆中十种抗癫痫药物及其在治疗药物监测中的应用
J Sep Sci. 2016 Mar;39(5):964-72. doi: 10.1002/jssc.201501067. Epub 2016 Jan 28.
10
Development and Validation of High-Throughput Bioanalytical Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) Method for the Quantification of Newly Synthesized Antitumor Carbonic Anhydrase Inhibitors in Human Plasma.开发和验证高通量生物分析液相色谱-串联质谱(LC-MS/MS)方法,用于定量人血浆中新合成的抗肿瘤碳酸酐酶抑制剂。
Molecules. 2020 Dec 6;25(23):5753. doi: 10.3390/molecules25235753.

引用本文的文献

1
Case Report: dose adjustment of orelabrutinib for managing central nervous system post-transplant lymphoproliferative disorder following acute lymphoblastic leukemia transplantation.病例报告:奥雷巴替尼用于急性淋巴细胞白血病移植后中枢神经系统移植后淋巴细胞增生性疾病的剂量调整。
Front Immunol. 2025 Jun 26;16:1597119. doi: 10.3389/fimmu.2025.1597119. eCollection 2025.
2
Development, validation, and clinical application of LC-MS/MS method for simultaneous determination of ibrutinib, zanubrutinib, orelabrutinib, acalabrutinib, and their active metabolites in patients with B-cell lymphoma.用于同时测定B细胞淋巴瘤患者中伊布替尼、泽布替尼、奥雷巴替尼、阿卡拉布替尼及其活性代谢物的液相色谱-串联质谱法的开发、验证及临床应用
Anal Bioanal Chem. 2025 Feb;417(4):821-834. doi: 10.1007/s00216-024-05701-2. Epub 2024 Dec 19.
3
Recent advances in the biosynthesis and industrial biotechnology of Gamma-amino butyric acid.γ-氨基丁酸生物合成与工业生物技术的最新进展
Bioresour Bioprocess. 2024 Mar 16;11(1):32. doi: 10.1186/s40643-024-00747-7.
4
Update and Application of a Deep Learning Model for the Prediction of Interactions between Drugs Used by Patients with Multiple Sclerosis.用于预测多发性硬化症患者用药间相互作用的深度学习模型的更新与应用
Pharmaceutics. 2023 Dec 19;16(1):3. doi: 10.3390/pharmaceutics16010003.